Breast biopsy developer Mammotome has launched HydroMark Plus, a new breast biopsy site marker.
HydroMark Plus is intended to improve lesion visibility on ultrasound and decrease the incidence of displacement during surgical procedures, the company said. It is the latest addition to Mammotome's HydroMark portfolio, and it will be available in the U.S. by the end of the year, according to the firm.